NeurologyLive® Friday 5 — July 7, 2023

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 7, 2023.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Key Updates in the Management of Neuromyelitis Optica Spectrum Disorder

A panel of experts in the treatment of patients with NMOSD discusses and offers insight into the vital aspects of diagnosis, disease management, and therapeutic strategy.

Key Updates in the Management of Neuromyelitis Optica Spectrum Disorder

2: Peer Exchange: Immunogenicity of Biosimilars

In episode 4 of this Peer Exchange series "How Similar are Biosimilars? A look into the Future with Biosimilars in Multiple Sclerosis", Amy Perrin Ross, APN, Patricia Melville, NP-C, and Aliza Ben-Zacharia, PhD, DNP, ANP-BC discuss importance of evaluating immunogenicity of biosimilars.

Immunogenicity of Biosimilars

3: NeuroVoices: Burel Goodin, PhD, on Building Trust in Underserved Communities to Improve Clinical Trial Outcomes

In the latest edition of our in-depth Q&A series, the professor of anesthesiology at Washington University in St. Louis discussed the importance of effectively communicating and reciprocating with underserved communities that are of research interest.

Burel Goodin, PhD, on Building Trust in Underserved Communities to Improve Clinical Trial Outcomes

4: Impacts of Daylight Savings Time on Sleep, Overall Health: Karin Johnson, MD, FAASM

The professor of neurology at UMass Chan School of Medicine discussed the various impacts Daylight Savings Time has on sleep quality and overall health in children and adolescents. [WATCH TIME: 3 minutes]

Impacts of Daylight Savings Time on Sleep, Overall Health: Karin Johnson, MD, FAASM

5: The Changing Landscape of Parkinson Disease and New Therapies on the Horizon: Mazen Elkurd, DO

The director of the Movement Disorders Center at Baylor University Medical Center in Dallas, a part of Baylor Scott & White Health, talked about the evolution of treatment for Parkinson disease and the new promising therapies patients may seen over the coming years. [WATCH TIME: 3 minutes]

The Changing Landscape of Parkinson Disease and New Therapies on the Horizon: Mazen Elkurd, DO
Related Videos
Ro'ee Gilron, PhD
Monica Verduzco-Gutierrez, MD
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.